These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 29627150)
21. [New direct oral oral anticoagulants (DOACs) - indications of DOACs]. Darius H Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238 [TBL] [Abstract][Full Text] [Related]
22. Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience. Eikelboom J; Merli G Am J Med; 2016 Nov; 129(11S):S33-S40. PubMed ID: 27586367 [TBL] [Abstract][Full Text] [Related]
23. Bleeding risks with novel oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and network meta-analysis. Lu D; Zhang Q; Liu Q; Wang K; Wang S; Shan Q J Interv Card Electrophysiol; 2015 Nov; 44(2):105-11. PubMed ID: 26342485 [TBL] [Abstract][Full Text] [Related]
24. The Effect of Direct Oral Anticoagulant Therapy (DOACs) on oral surgical procedures: a systematic review. Darwish G BMC Oral Health; 2023 Oct; 23(1):743. PubMed ID: 37821865 [TBL] [Abstract][Full Text] [Related]
25. Novel oral anticoagulants and exodontia: the evidence. Nathwani S; Wanis C Br Dent J; 2017 Apr; 222(8):623-628. PubMed ID: 28428567 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Rollins BM; Silva MA; Donovan JL; Kanaan AO Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394 [TBL] [Abstract][Full Text] [Related]
28. [Management of direct oral anticoagulants for invasive procedures]. Godier A; Gouin-Thibault I; Rosencher N; Albaladejo P; J Mal Vasc; 2015 May; 40(3):173-81. PubMed ID: 25778841 [TBL] [Abstract][Full Text] [Related]
29. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis. Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644 [TBL] [Abstract][Full Text] [Related]
30. Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Proietti M; Romanazzi I; Romiti GF; Farcomeni A; Lip GYH Stroke; 2018 Jan; 49(1):98-106. PubMed ID: 29167388 [TBL] [Abstract][Full Text] [Related]
31. Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy. Hanken H; Gröbe A; Heiland M; Smeets R; Kluwe L; Wikner J; Koehnke R; Al-Dam A; Eichhorn W Clin Oral Investig; 2016 Jul; 20(6):1279-82. PubMed ID: 26498769 [TBL] [Abstract][Full Text] [Related]
32. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry. Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155 [TBL] [Abstract][Full Text] [Related]
33. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data. Tummala R; Kavtaradze A; Gupta A; Ghosh RK Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776 [TBL] [Abstract][Full Text] [Related]
34. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis. Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495 [TBL] [Abstract][Full Text] [Related]
35. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin. Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997 [TBL] [Abstract][Full Text] [Related]
36. Direct oral anticoagulants: new drugs and new concepts. Levy JH; Spyropoulos AC; Samama CM; Douketis J JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529 [TBL] [Abstract][Full Text] [Related]
37. Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Ntaios G; Papavasileiou V; Makaritsis K; Vemmos K; Michel P; Lip GYH Stroke; 2017 Sep; 48(9):2494-2503. PubMed ID: 28716982 [TBL] [Abstract][Full Text] [Related]
38. An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants. Deitelzweig S; Bruno A; Trocio J; Tate N; Gupta K; Lin J; Lingohr-Smith M Curr Med Res Opin; 2016; 32(3):573-82. PubMed ID: 26652179 [TBL] [Abstract][Full Text] [Related]
39. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy. Kido K; Scalese MJ Ann Pharmacother; 2017 Nov; 51(11):1000-1007. PubMed ID: 28639882 [TBL] [Abstract][Full Text] [Related]
40. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis. Xu WW; Hu SJ; Wu T J Zhejiang Univ Sci B; 2017 Jul; 18(7):567-576. PubMed ID: 28681581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]